1. |
中华医学会血液学分会红细胞疾病(贫血)学组. 中国输血依赖型β地中海贫血诊断与治疗指南(2022年版)[J]. 中华血液学杂志, 2022, 43(11): 889-896. DOI: 10.3760/cma.j.issn.0253-2727.2022.11.002.Red Blood Cell Diseases (Anemia) Group, Hematology Society, Chinese Medical Association. Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)[J]. Chin J Hemat, 2022, 43(11): 889-896. DOI: 10.3760/cma.j.issn.0253-2727.2022.11.002.
|
2. |
邵超鹏, 骆群, 伍昌林. 输血依赖型地中海贫血(TDT)患者临床输血中国专家共识[J]. 临床输血与检验, 2023, 25(2): 163-169. DOI: 10.3969/j.issn.1671-2587.2023.02.002.Shao CP, Luo Q, Wu CL. Chinese expert consensus on clinical transfusion of transfusion-dependent thalassemia (TDT) patients[J]. J Clin Transfus Lab Med, 2023, 25(2): 163-169. DOI: 10.3969/j.issn.1671-2587.2023.02.002.
|
3. |
Akritidou F, Praidou A, Papamitsou T, et al. Ocular manifestations in patients with transfusion-dependent β-thalassemia[J]. Hippokratia, 2021, 25(2): 79-82.
|
4. |
Suhana D, Krishnapada B, Madhumita B, et al. Retinal nerve fibre layer thinning in patients with thalassaemia, iron deficiency anaemia, and anaemia of chronic diseases[J/OL]. J Ophthalmol, 2020, 2020: 9268364[2020-11-18]. https://pubmed.ncbi.nlm.nih.gov/33282416/. DOI: 10.1155/2020/9268364.
|
5. |
AttaAllah HR, Mousa SO, Omar IAN, et al. Correction to: macular microvascular changes in children with transfusion-dependent beta-thalassemia[J]. Graefe's Arch Clin Exp Ophthalmol, 2022, 260(4): 1431. DOI: 10.1007/s00417-022-05555-3.
|
6. |
Cennamo G, Montorio D, Mazzella G, et al. Retinal and choriocapillaris vascular changes in patients affected by different clinical phenotypes of β-thalassemia: an optical coherence tomography angiography study[J]. Biology, 2021, 10(4): 276. DOI: 10.3390/biology10040276.
|
7. |
Haghpanah S, Zekavat OR, Safaei S, et al. Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia[J]. BMC Ophthalmol, 2022, 22(1): 279. DOI: 10.1186/s12886-022-02490-z.
|
8. |
Kurnia KH, Elvioza, Sidik M, et al. Novel retinal findings in β-thalassemia major: older age and higher ferritin level as the risk factors[J]. Graefe's Arch Clin Exp Ophthalmol, 2021, 259(9): 2633-2641. DOI: 10.1007/s00417-021-05141-z.
|
9. |
Georgalas I, Makris G, Papaconstantinou D, et al. A pilot optical coherence tomography angiography study on superficial and deep capillary plexus foveal avascular zone in patients with beta-thalassemia major[J]. Invest Ophthalmol Vis Sci, 2019, 60(12): 3887-3896. DOI: 10.1167/iovs.19-27291.
|
10. |
Di Nicola M, Barteselli G, Dell'Arti L, et al. Functional and structural abnormalities in deferoxamine retinopathy: a review of the literature[J/OL]. Biomed Res Int, 2015, 2015: 249617[2015-06-08]. https://pubmed.ncbi.nlm.nih.gov/26167477/. DOI: 10.1155/2015/249617.
|
11. |
Georgakopoulos CD, Tsapardoni F, Kostopoulou EV, et al. Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature[J]. BMC Ophthalmol, 2018, 18(1): 246. DOI: 10.1186/s12886-018-0911-2.
|
12. |
Wu CH, Yang CP, Lai CC, et al. Deferoxamine retinopathy: spectral domain-optical coherence tomography findings[J]. BMC Ophthalmol, 2014, 14(1): 88. DOI: 10.1186/1471-2415-14-88.
|
13. |
Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia[J]. Blood, 1997, 89(3): 739-761. DOI: 10.1182/blood.V89.3.739.
|
14. |
El-Shazly AA, Ebeid WM, Elkitkat RS, et al. Electroretinographic and visual-evoked potential changes in relation to chelation modality in children with thalassemia[J]. Retina, 2017, 37(6): 1168-1175. DOI: 10.1097/IAE.0000000000001315.
|
15. |
Borgna-Pignatti C, Gamberini MR. Complications of thalassemia major and their treatment[J]. Expert Rev Hematol, 2011, 4(3): 353-366. DOI: 10.1586/ehm.11.29.
|
16. |
Barteselli G, Dell'arti L, Finger RP, et al. The spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum[J]. Ophthalmology, 2014, 121(3): 709-718. DOI: 10.1016/j.ophtha.2013.10.016.
|
17. |
Incorvaia C, Parmeggiani F, Costagliola C, et al. Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major[J]. Eye (Lond), 2003, 17(3): 324-329. DOI: 10.1038/sj.eye.6700352.
|
18. |
Stultz RD, Conti FF, Kumar JB, et al. Beta-thalassemia minor manifesting as proliferative retinopathy[J/OL]. Ophthalmic Surg Lasers Imaging Retina, 2018, 49(10): e161-e164[2018-10-01]. https://pubmed.ncbi.nlm.nih.gov/30395680/. DOI: 10.3928/23258160-20181002-22.
|
19. |
Abraham A. Bull's eye maculopathy possibly due to iron overload in a child with thalassemia major: a case of possible "ferritin retinopathy"[J]. Retin Cases Brief Rep, 2021, 15(4): 482-485. DOI: 10.1097/ICB.0000000000000834.
|
20. |
Aksoy A, Aslan L, Aslankurt M, et al. Retinal fiber layer thickness in children with thalessemia major and iron deficiency anemia[J]. Semin Ophthalmol, 2014, 29(1): 22-26. DOI: 10.3109/08820538.2013.839811.
|
21. |
Arifoglu HB, Kucuk B, Duru N, et al. Assessing posterior ocular structures in β-thalassemia minor[J]. Int Ophthalmol, 2018, 38(1): 119-125. DOI: 10.1007/s10792-016-0431-0.
|
22. |
Pakdel F, Pirmarzdashty N, Sanjari MS, et al. Optic atrophy in thalassemia intermedia[J]. J Neuroophthalmol, 2011, 31(3): 252-254. DOI: 10.1097/WNO.0b013e31821ee59d.
|
23. |
Sorcinelli R, Cacace E, Del Piano M. Optic nerve compression by extramedullary hematopoietic tissue in a patient suffering from beta-thalassemia intermedia[J]. Metab Pediatr Syst Ophthalmol, 1999, 22: 5-6.
|
24. |
Heydarian S, Jafari R, Dailami KN, et al. Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies[J]. Int Ophthalmol, 2020, 40(2): 511-527. DOI: 10.1007/s10792-019-01189-3. DOI: 10.1007/s10792-019-01189-3.
|
25. |
Simsek A, Tekin M, Bilak S, et al. Choroidal thickness in children with beta thalassemia major[J]. Optom Vis Sci, 2016, 93(6): 600-606. DOI: 10.1097/OPX.0000000000000833.
|
26. |
AttaAllah HR, Mousa SO, Omar IAN. Macular microvascular changes in children with transfusion-dependent beta-thalassemia[J]. Graefe's Arch Clin Exp Ophthalmol, 2021, 259(11): 3283-3293. DOI: 10.1007/s00417-021-05275-0.
|
27. |
Kiarudi MY, Fadakar K, Mousavi E. Bilateral choroidal neovascularization in a patient with beta-thalassemia major and its management[J]. Retin Cases Brief Rep, 2018, 12(3): 224-227. DOI: 10.1097/ICB.0000000000000460.
|
28. |
Bhoiwala DL, Dunaief JL.Retinal abnormalities in β-thalassemia major[J]. Surv Ophthalmol, 2016, 61(1): 33-50. DOI: 10.1016/j.survophthal.2015.08.005.
|
29. |
Baig R, Zahid N, Kausar F, et al. Burden of ocular abnormalities in patients with beta thalassaemia: a cross-sectional study[J/OL]. BMJ Open Ophthalmol, 2023, 8(1): e001293[2023-07-01]. https://pubmed.ncbi.nlm.nih.gov/37493812/. DOI: 10.1136/bmjophth-2023-001293.
|
30. |
中华医学会医学遗传学分会遗传病临床实践指南撰写组. β-地中海贫血的临床实践指南[J]. 中华医学遗传学杂志, 2020, 37(3): 243-251. DOI: 10.3760/cma.j.issn.1003-9406.2020.03.004.Genetic Disease Clinical Practice Guideline Writing Group, Chinese Medical Association Branch of Medical Genetics. Clinical practice guidelines for β-thalassemia[J]. Chin J Medl Genet, 2020, 37(3): 243-251. DOI: 10.3760/cma.j.issn.1003-9406.2020.03.004.
|